As of April 2026, more than 40 million GLP-1 receptor agonist prescriptions are dispensed annually in the United States alone ...

HCM causes the heart muscle to abnormally thicken, making it harder for the heart to pump blood effectively. According to the ...

Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop ...

The identification of a receptor that is recognized by a subset of alphacoronaviruses provides insights into ‘spillover’ risk ...

New study led by Tufts University researchers found prediabetic adults with certain variations in the vitamin D receptor gene had a 19% lower risk of developing diabetes when taking a high daily dose ...

Scientists are aiming to determine the composition and topology of physiological Ashwell-Morell receptor ligands. Their findings will help uncover the receptor's still-hidden secrets. After earning ...

Researchers have identified a receptor, Smoothened, that regulates how the adult brain locks in or overwrites learned behaviors by controlling the timing of neurotransmitter pauses in the striatum.

Can weight-loss drugs like semaglutide prevent Alzheimer's? New research reveals GLP-1 drugs reduce amyloid and tau proteins ...

Details and references regarding individual diseases are provided in the Supplementary Appendix. CIDP denotes chronic inflammatory demyelinating polyneuropathy, Covid-19 coronavirus disease 2019, and ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

Activation of the serotonin receptor, 5-HT1A, has been shown to regulate mood and cognition. The receptor is the primary target of buspirone, vilazodone, and gepirone, FDA-approved medications for the ...